
Xilinx Acquires Silexica to Broaden its Developer Base Jun 10, 2021
SAN JOSE, Calif.--(BUSINESS WIRE)-- Xilinx, Inc. (NASDAQ: XLNX), the leader in adaptive computing, today announced that it has acquired Silexica, a privately-held provider of C/C programming and analysis tools. Silexica's SLX FPGA tool suite empowers developers with an unparalleled development experience building applications on FPGAs and Adaptive SoCs. This technology will become integrated with the Xilinx Vitis unified software platform to substantially reduce the learning curve for software developers building sophisticated applications on Xilinx technology.
Leveraging standard high-level synthesis tools from Xilinx, the SLX FPGA tool suite tackles non-synthesizable and non-hardware aware C/C code, detects application parallelism, inserts pragmas, and determines optimal software and hardware partitioning. This enables designing at a higher level of abstraction, orders of magnitude faster simulation, and a better result through high-level optimizations and design space exploration.
Software programmability is imperative to our long-term goal to accelerate the path from software to application-optimized hardware systems, says Salil Raje, executive vice president and general manager, Data Center Group, Xilinx. Silexica's technology complements our existing Vitis solution and roadmap and will accelerate our ability to attract a wider range of developers seeking to leverage our heterogeneous computing architectures.
Silexica's vision is to create a disruptive developer tool - one that closes the gap between the software and hardware developer domains, says Maximilian Odendahl, former CEO of Silexica. The integration of our technology with the Xilinx Vitis portfolio fully aligns with our goal of making adaptive computing accessible to software developers. We are excited to continue the journey as part of the Xilinx Vitis team.
After six years of cutting-edge academic research, Silexica was spun out of RWTH Aachen University in 2014. Its headquarters are in Cologne, Germany, with offices in Silicon Valley and Japan. It serves innovative companies in the automotive, robotics, wireless communications, aerospace, and financial industries and has received $28 million in funding from international investors.
Financial details and the terms of the transaction are not being disclosed. More information on Xilinx Vitis unified software platform is available here. You can sign up for developer-related updates here. For information on Xilinx and its adaptable, intelligent technologies, please visit www.xilinx.com.
Follow Xilinx on Twitter, LinkedIn and Facebook.
About Xilinx
Xilinx, Inc. develops highly flexible and adaptive processing platforms that enable rapid innovation across a variety of technologies - from the cloud, to the edge, to the endpoint. Xilinx is the inventor of the FPGA and Adaptive SoCs (including our Adaptive Compute Acceleration Platform, or ACAP), designed to deliver the most dynamic computing technology in the industry. We collaborate with our customers to create scalable, differentiated and intelligent solutions that enable the adaptable, intelligent and connected world of the future. For more information, visit www.xilinx.com.
Source: Xilinx Newsroom
Category: Company Announcements
Copyright 2021 Xilinx, Inc. Xilinx, the Xilinx logo, Vitis, Vivado and other designated brands included herein are trademarks of Xilinx in the United States and other countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210610005090/en/
Xilinx PR
media@xilinx.com
Source: Xilinx, Inc.
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
07/10/2026
Dalet, a leading technology and service provider for media-rich organizations, today announced the latest Long-Term Supported (LTS) release of Dalet Flex. Build...
06/09/2026
June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
At IBC2026, MediaKind will make its first major appearance as a unified global powerhouse in video, showcasing one of the world's most comprehensive video i...
06/08/2026
Big Blue Marble (#5.A63) will demonstrate how its integrated technology and operational expertise help media companies scale premium services with less complexi...
06/08/2026
LA JOLLA, CA-Scripps Research has received more than $500,000 in first-year fund...
06/08/2026
LA JOLLA, CA-Viruses are masters at invading our cells thanks to specialized proteins that coat their surfaces. When scientists design vaccines, they often crea...
06/08/2026
LA JOLLA, CA-The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in Alzheimer's disea...
06/08/2026
LA JOLLA, CA-Scripps Research chemist Jin-Quan Yu has been elected to the National Academy of Sciences (NAS), one of the highest honors a scientist can achieve....
06/08/2026
LA JOLLA, CA-Scripps Research ranked third in the inaugural 2026 Cure Innovation Index recognizing the top-performing institutes and centers across the United S...
06/08/2026
Benjamin Cravatt, the Gilula Chair of Chemical Biology and a professor of chemis...
06/08/2026
LA JOLLA, CA-Dennis Burton, professor and the James & Jessie Minor Chair in Immu...
06/08/2026
LA JOLLA, CA-Inside every human cell, proteins are constantly being tagged with small chemical modifications after they're produced. Known as post-translati...
06/08/2026
LA JOLLA-Scripps Research has established the Ian Wilson Endowed Chair, a new fa...
06/08/2026
Scripps Research's Skaggs Graduate School of Chemical and Biological Science...
06/08/2026
LA JOLLA, CA-Professor Jin-Quan Yu of Scripps Research has been elected to the Fellowship of the Royal Society, the U.K.'s national academy of sciences and ...
06/08/2026
LA JOLLA, CA-For years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain of the quickly mutati...
06/08/2026
LA JOLLA, CA-The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit...
06/08/2026
LA JOLLA, CA-Building the complex 3D molecules needed for new medicines has alwa...
06/08/2026
LA JOLLA, CA-Fentanyl and related variants of the synthetic opioid kill more Americans each year than car accidents and gun violence combined. In too-high doses...
06/08/2026
LA JOLLA, CA-What do decoding communication between organs and reimagining the future of genome editing have in common? They're among the scientific questio...
06/08/2026
LA JOLLA, CA-Of the 1.2 million people living with HIV in the United States, app...
06/08/2026
LA JOLLA, CA-For some people, cancer immunotherapies are life-changing. These treatments can turn the body's own immune system against a tumor, either elimi...
06/08/2026
LA JOLLA, CA-Many conditions that cause vision loss share a common feature: the ...
06/08/2026
LA JOLLA, CA-RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.
Crowned with the 2006 Nobel Priz...
06/08/2026
LA JOLLA, CA-The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows that an anti-inflammato...
06/08/2026
LA JOLLA, CA-Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone. As mor...
06/08/2026
LA JOLLA, CA-Some of the world's best-selling diabetes drugs depend on a che...
06/08/2026
LA JOLLA, CA-Detecting infectious disease threats early and responding quickly can dramatically alter the course of an infectious outbreak. Technologies such as...
06/08/2026
LA JOLLA, CA-Molecular biophysicist Joan Pulupa will join Scripps Research in Ja...
06/08/2026
LA JOLLA, CA-HIV is globally so diverse, consisting of hundreds of thousands of ...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
At this year's SET EXPO, PlayBox Neo will present recent innovations across its PlayBox Neo Suite and integrated range of broadcast media solutions. By show...
06/08/2026
Live demo at IBC2026 VisualOn Booth, Hall 5, Stand A55
Amsterdam, Netherlands Modern Streaming Solutions Private Limited, a rising force in India's dig...
06/08/2026
Screen Australia and YouTube Australia fund five new teams through eleventh Skip...
06/08/2026
How Karukera Studio Built a Media Production Hub with SNS EVO
Melanie Ciotti August 5, 2026
0 Comments
Hero images displays Karukera Studio in Sainte-...
06/08/2026
NHK drama series Rosanjin no Kamado shot on PYXIS 6K
Brie Clayton August 5, 2026
0 Comments
Blackmagic PYXIS 6K and DaVinci Resolve Studio capture the...
06/08/2026
Camera Match: AutoSetup 3d Plugin / script for Photomontages- Cinema 4D
Jamie Cardoso August 5, 2026
0 Comments
If you do any kind of Architectural Vi...
06/08/2026
In Time airs Monday 10 August at 9.35pm on RT One and RT Player
In Time is the first film account of the life of D nal Lunny, one of the most influential Iri...
06/08/2026
Editor's note: This post is part of Into the Omniverse, a series focused on how developers, 3D practitioners and enterprises can transform their workflows u...
06/08/2026
August is here, bringing 26 new games for GeForce NOW members.
Command the seas in World of Warships: Legends and discover what's next in the GeForce NOW ...
05/08/2026
Thomson's Climate Crisis Toolkit for Media in Tanzania is being included in a new virtual library designed to ensure accurate and engaging storytelling arou...
05/08/2026
RSNs, teams, leagues, and streamers explore the present and future of local spor...
05/08/2026
As sports-production workflows generate larger volumes of unstructured data and ...